Former President Jimmy Carter said this month that immunotherapy treatment has shrunk melanoma tumors.
December 9, 2015 Jimmy Carter seems to have gotten the perfect drug to treat his cancer. But scientists need to understand a lot more about tumors before personalized cancer treatments are available for everyone.
September 1, 2015 Statins made her feel wretched, so she took a DNA test to find out why. But even the doctor with the genetic testing company admits that the test doesn't tell you much more than you already know.
Studies show that having too many tests done too frequently is a recipe for getting sick, not staying healthy.
April 6, 2015 Why not check bloodwork a few times a year as some celebrities advise? Because too much testing can lead to false positives (and abnormalities that don't threaten health) and to unnecessary treatment.
Whether you live in the city or the countryside can affect your health and susceptibility for disease.
October 31, 2014 Where do you live? Health specialists think that simple question could make a difference in how doctors prevent and treat diseases for individuals. That's expanding its storied role in public health.
November 25, 2013 People's genes can affect how they'll respond to blood thinners and cancer drugs. But inaccurate results can lead to bad medical decisions. Regulators are pushing back against a company that has been among the most aggressive in marketing personal genetic testing directly to consumers.
Whether or not you'll someday get cancer or any disease can feel like a roll of hundreds of dice. Calculating the odds -- and knowing what they mean -- is tricky.
August 18, 2013 There's a difference between knowing your breast cancer risk and believing it. When psychologists asked several hundred women to plug personal health data into an online tool that then calculated their breast cancer risk, nearly 20 percent rejected their scores as wrong.
March 8, 2012 Detailed tests in kidney cancer patients. help explain why some treatments may not be successful. And they underscore the challenge in developing personalized tests and drugs for effective cancer therapy.
NPR thanks our sponsors
Become an NPR sponsor